Click on the headers below to read more information about other W&M Policies
Displays IRB policies
IBC and IRB Protocols
A protocol will need to be submitted to both committees when:
it involves the transfer of recombinant DNA or DNA/RNA derived from recombinant DNA (human gene transfer). Recombinant and synthetic nucleic acids are defined as:
molecules that are constructed by joining nucleic acid molecules and that can replicate in a living cell, i.e. recombinant nucleic acids,
molecules that are chemically or by other means synthesized or amplified, including those that are chemically or otherwise modified but can base pair with naturally occurring nucleic acid molecules, i.e. synthetic nucleic acids,
molecules that result from the replication of those described in (i) or (ii) above.
using infectious agents with research participants
the IBC protocol involves the use of human research participants or identifiable human biospecimens
An IRB protocol submission is not required to the IBC If the researcher is only collecting, storing, or shipping specimens.
Either IRB approval or IBC approval can be sought first. However, once approval is obtained, the approval notice must be appended to the protocol submitted to the other committee via a modification or amendment.
W&M Policy for Paying Human Participants
Accounts Payable lists policies related to paying human participants. Please follow the links below for more information.
